List view / Grid view

Betty Pace

 

article

New drug boosts foetal haemoglobin to fight sickle cell disease

Researchers are exploring the potential use of HDAC inhibitors, a…

18 May 2023 | By

Researchers are exploring the potential use of HDAC inhibitors, a group of drugs known for their capability to impede tumour cell division, to reduce the pain and damage associated with sickle cell disease. The drugs have shown initial evidence of reactivating the gene responsible for producing foetal haemoglobin, which cannot…